The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > China in High Risk Regulatory Phase, According to CFDA Commissioner

China in High Risk Regulatory Phase, According to CFDA Commissioner

Posted 15 August 2013 | By Louise Zornoza

In a recent interview with the press, China Food and Drug Administration (CFDA) Commissioner Zhang Yong noted that the country has entered a development phase for regulated industry that is marked by a high incidence of safety risks. 

He attributes this current phase to the country's rapid economic development, which has also led to the rapid growth of local regulated industry.  Based on international experience as a reference point, China's regulated industry is still burdened by imperfect self-regulation and the need for better recognition of the importance of product safety and quality.

In his opinion, there is a close relationship between product safety and quality and a country's social and economic development, and the public is now demanding that from industry.

SFDA Statement on Interview

Read all Breaking News from RegLink


© 2021 Regulatory Affairs Professionals Society.

Tags: SFDA

Regulatory Focus newsletters

All the biggest regulatory news and happenings.